With homage to Arthur Lipper, a mentor and friend

While running a medical device manufacturer (this is a vagary in our regulatory environment; in any other country this venture would have been a pharmaceutical operation), we routinely analyzed our operations and updated our business plans.  We had an outside Board, who provided us with invaluable insight- and a counterbalance to our (inherently inward bound and) parochial focus.  Whenever we considered a new option or product addition, Arthur always asked, “What are the barriers to entry by our competitors?” That valuable lesson (among many others provided by Arthur, Bob Boyle [a’h], and Bill Weissert to us) is one I want to share with you today.

Continue reading Barriers to Entry →

Share this: